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Abstract
Myocardial perfusion imaging (MPI) is widely used in routine 
practice for diagnosis and risk stratification of coronary artery 
disease (CAD). Intense curvilinear activity in the stomach wall 
of a patient was seen on MPI raw data. This phenomenon 
was completely dissimilar to the familiar intraluminal gastric 
reflux of sestamibi. This observed activity could have resulted 
in false-positive or false-negative artifacts — and inaccurate 
diagnosis — of the inferior wall of the left ventricle after MPI pro-
cessing. On further exploration, the current researchers found 
that the patient had a history of 10-year Omeprazole capsule 
consumption. The authors present this infrequent case of intense 
stomach uptake to stress the related clinical and diagnostic im-
plications with the aim to stimulate acute awareness of possible, 
unexpected infringements on image quality that could potentially 
interfere with accurate interpretation of the data. 
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Introduction
Myocardial perfusion imaging (MPI) with exercise or pharma-
cological stress, either with thallium-201 (201Tl) or technetium-99m 
(99mTc)-sestamibi, is widely used for preparation of diagnostic and 
prognostic information regarding patients with proved or possible 
coronary artery disease (CAD) and it facilitates the accurate ma-
nagement of CAD patients [1]. However, with present myocardial 
radiotracers, such as 99mTc-sestamibi, rather high extra-cardiac 
activity is usually seen, which is mostly associated with physiologic 
hepatobiliary or renal excretion [2]. In contrast, there are limited 
reports suggesting possible non-physiologic reasons for these 
visceral uptakes, and occasionally, indicating different underlying 
pathologies [2]. Indeed, accidental pathological ﬁ ndings during 
myocardial perfusion imaging are not scarce and cautious examina-
tion of the full ﬁ eld of image acquisition has been useful in identifying 
these accidental ﬁ ndings [3–5]. Alternatively, most efforts concen-
trate on dissolving these interfering abdominal activities without 
attention to the clinical importance of such ﬁ ndings [6, 7].
On the MPI raw data of one such patient, intense curvili-
near activity in the stomach wall was evident. This phenomenon 
was completely dissimilar to the familiar intraluminal gastric 
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reﬂ ux of sestamibi. This observed activity could have resulted in 
false-positive or false-negative artifacts — and inaccurate diagno-
sis — of the inferior wall of the left ventricle after MPI processing. 
On further exploration, the current researchers found that the patient 
had a history of 10-year Omeprazole capsule consumption. The 
authors present this infrequent case of intense stomach uptake to 
stress the related clinical and diagnostic implications with the aim 
to stimulate acute awareness of possible, unexpected infringe-
ments on image quality that could potentially interfere with accurate 
interpretation of the data. 
Case report
A 54-year-old woman with an atypical chest pain was referred 
to the nuclear medicine department for assessment of possible 
coronary artery disease. The patient ﬁ lled out a questionnaire that 
included demographics and risk factors for CAD. She had not had 
previous coronary artery bypass surgery (CABG) or percutane-
ous coronary intervention (PCI). The patient underwent a 2-day 
dipyridamole technetium 99m-sestamibi SPECT protocol. All car-
diovascular medications were stopped for at least 2 days and the 
Figure 1. There is curvilinear activity with more intensity in the stomach wall than in the heart on both stress (A) and rest (B) raw data of myocardial 
perfusion imaging (MPI) using 99mTc-sestamibi SPECT. H, heart; S, stomach
A B
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patient fasted overnight prior the test. Dipyridamole (0.56 mg/kg) 
as a pharmacologic agent was infused over 4 min. Patient symp-
toms and a 12-lead ECG were monitored continuously. A dose of 
740 MBq of Tc-99m sestamibi as a compact bolus was injected 
4 min after the beginning of the infusion. After twenty minutes, the 
patient was requested to drink two glasses of fatty milk to hasten 
hepatobiliary clearance of the Tc-99m sestamibi, and acquisition 
was performed 90 minutes after the initial infusion of dipyridamole. 
The following day was the rest phase of the test. 
During the processing of the raw data, the authors observed 
intense curvilinear activity in the stomach wall, which was identical 
in shape and intensity to stress and rest sets (Figure 1A, B). The 
intensity of the gastric wall activity was considerably higher than the 
patient’s heart activity. The authors asked about her past medical 
history regarding gastrointestinal problems, including hiatus hernia, 
peptic ulcer disease, indigestion, heart burn, an acid reﬂ ux problem, 
previous procedures (gastric surgery), and other medical records. 
The patient explained that she experienced epigastric discomfort 
and nausea about ten years ago; a gastroenterologist prescribed 
her Omeprazole capsules (20 mg) daily. Her symptoms subsided 
after taking this capsule; so, she had been taking it since that date 
by self-prescription. 
Discussion
Myocardial perfusion imaging with 99mTc-labeled agents is used 
wildly for the diagnosis and risk stratiﬁ cation of CAD [1]. In spite of 
all the beneﬁ ts of 99mTc-MIBI myocardial perfusion imaging, the 
radiopharmaceutical has some extra-cardiac uptake, frequently in 
the stomach, liver, bowel, and spleen [8], which can interfere with 
accurate interpretation of the MPI [9]. Several techniques have 
been tried, with mixed results, to reduce the effect of extra-cardiac 
activity on the interpretation of the images, including delaying the 
imaging, ingesting water, milk, or food, altering the patient’s posi-
tion, or using various prokinetic medications [9–11].
This case showed that stomach wall uptake was strongly as-
sociated with prolonged use of PPIs. The intense stomach wall 
99mTc-sestamibi activity was not washed out by the ingestion of 
milk and was the same on both stress and rest sets. 
In the literature, a number of studies have demonstrated the 
association of this activity with dyspepsia [12–14], but to the au-
thors’ knowledge, only one investigation reported its association 
with consumption of PPIs [15]. In a Khary et al study on 39 pa-
tients who underwent dipyridamole 201 Tl stress tests, a stepwise 
logistic regression analysis revealed that only two variables had 
predictive value in 201 Tl gastric uptake: the presence of active 
gastritis symptoms and the use of anti-gastritis medications [12]. 
In another study by Côté et al, on a group of 819 patients who 
underwent 99m Tc-sestamibi cardiac, single photon emission, 
computed tomography (SPECT), 13 patients (1.6%) depicted sig-
niﬁ cant gastric-wall hyperactivity. They concluded that this ﬁ nding 
was associated with dyspepsia [13].
In a similar study by Gholamrezanezhad et al. on 1056 patients, 
1.9% of participants were identiﬁ ed with gastric wall hyperacti -
vity [14]. In addition, this study classiﬁ ed gastric wall activity 
qualitatively as G1, or hyperactive gastric wall (equivalent to the 
patient’s heart activity), or G2 (less than heart activity), and showed 
that dyspeptic symptoms were present in 80% and 18.6% of G1 
and G2 patients, respectively (p < 0.001) [14].
Furthermore, Goel et al. compared the effect of proton pump 
inhibitors and H2 antagonists on the stomach wall activity in 121 
patients who underwent 99m Tc-sestamibi cardiac SPECT [15]. 
In total, 26 and 14 patients were taking PPIs and H2 antagonists, 
respectively. Taking of proton pump inhibitors was deﬁ ned by more 
than 2 weeks duration. No patients were taking both medications. 
Stomach wall activity was strongly related to prolonged use of 
PPIs (X2 = 51.9, P < 0.0001) [15]. They concluded that prolonged 
PPI therapy, but not H2 antagonist therapy, resulted in signiﬁ cant 
stomach wall activity [15]. 
The mechanism of impact of the PPIs on stomach-wall sesta-
mibi uptake is not obvious. 99mTc-sestamibi is a lipophilic cationic 
agent that is taken up by myocardial tissue in proportion to myo-
c ardial blood ﬂ ow and concentrated in mitochondria [1]. However, 
as a preliminary cause, it may concentrate through gastric parietal 
cells due to their abundant mitochondria; therefore, inhibition of the 
H1/K1 ATPase pump diminishes the secretion of sestamibi from the 
gastric wall into the gastric lumen in the same way that the decline 
of acid secretion would [15].
This case and previous reports may indicate that stomach 
wall activity, due to its proximity to the inferior myocardial wall, 
could cause either false-negative or false-positive myocardial 
perfusion SPECT ﬁ ndings resulting from either Compton scatter 
or ramp ﬁ lter artifacts. This suggests a need for more attention 
during the interpretation of MPI of patients, particularly those who 
are taking PPIs [15]. This paper recommends designing a clinical 
trial that compares gastric wall activity in patients who stop, and 
in patients who continue, the PPIs before scheduling myocardial 
perfusion scanning.
Additionally, although gastric wall hyperactivity on cardiac 
SPECT is infrequent, it may indicate a treatable cause of chest pain 
or contribute to distinguishing further diagnostic evaluation regard-
ing peptic ulcer or other gastric disorders. Therefore, a systematic 
review of the raw data before reading the speciﬁ c images and 
a report of the ﬁ ndings should be included in cardiac SPECT reports.
Conclusion
The presented case may demonstrate that gastric wall activity 
on 99m Tc-sestamibi cardiac SPECT images is associated with 
prolonged PPI use. The authors recommend taking a history of 
prolonged use of PPIs to predict the increased stomach wall 
99m Tc-sestamibi activity, which can interfere with the accuracy 
of a study. As a guide for further diagnostic tests, there should be 
a systematic review of the raw data before reading the images and 
a report of the ﬁ ndings should be included in cardiac SPECT reports.
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